Xbiotech announces agreement to sell true human antibody bermekimab targeting il-1a to janssen

Press release - xbiotech announces agreement to sell true human antibody bermekimab targeting il-1a to janssen.xbiotech may receive up to $600 million in potential milestone payments.xbiotech -co expects to generate additional revenue from manufacturing supply agreement, clinical services agreement with janssen over next 2 years.
XBIT Ratings Summary
XBIT Quant Ranking